Literature DB >> 26519683

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Antti Palomäki1, Pirjo Mustonen2, Juha E K Hartikainen3, Ilpo Nuotio4, Tuomas Kiviniemi5, Antti Ylitalo6, Päivi Hartikainen7, Heidi Lehtola8, Riho Luite9, K E Juhani Airaksinen10.   

Abstract

BACKGROUND: Cardioversion of atrial fibrillation (AF) is associated with an increased risk for stroke. We identified all cardioversions during the 30 days preceding stroke or transient ischemic attack (TIA) in patients with a previously diagnosed AF, and sought to assess the characteristics of cardioversions leading to stroke or TIA.
METHODS: FibStroke is a cross-sectional observational multicenter registry that included AF patients with an ischemic stroke or intracranial bleed identified from a discharge registry of four Finnish hospitals. In total 3677 consecutive AF patients suffered 3252 strokes and 956 TIA episodes during 2003–2012. This pre-specified analysis focused on the 1644 events that occurred to patients with paroxysmal or persistent AF at the time of stroke/TIA.
RESULTS: A total of 78 strokes and 22 TIA episodes were preceded by a cardioversion. Post-cardioversion strokes accounted for 6.4% of strokes in patients with paroxysmal/persistent AF. Of the 100 cardioversions leading to an ischemic event, 77 were acute and 23 were elective, 63 events occurred in patients not using anticoagulation, and 5 patients had periprocedural INR < 2. Importantly, 21 patients were in low risk of stroke, i.e. CHA2DS2-VASc score < 2. The median delay from cardioversion to event was 2 days. All nine patients who after an unsuccessful cardioversion developed a stroke had a spontaneous cardioversion prior to stroke.
CONCLUSIONS: Every sixteenth stroke of patients with paroxysmal/persistent AF is preceded by a cardioversion. Most post-cardioversion strokes occur in patients not using oral anticoagulation before cardioversion of acute AF.

Entities:  

Keywords:  Atrial fibrillation; Cardioversion; Stroke; Transient ischemic attack

Mesh:

Substances:

Year:  2015        PMID: 26519683     DOI: 10.1016/j.ijcard.2015.10.168

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  11 in total

1.  Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

Authors:  Antti Palomäki; Tuomas Kiviniemi; Juha E K Hartikainen; Pirjo Mustonen; Antti Ylitalo; Ilpo Nuotio; Päivi Hartikainen; Jussi Jaakkola; Riho Luite; K E Juhani Airaksinen
Journal:  Clin Cardiol       Date:  2016-05-30       Impact factor: 2.882

Review 2.  How to Optimize Cardioversion of Atrial Fibrillation.

Authors:  K E Juhani Airaksinen
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

3.  Does Duration of Symptoms Reliably Predict Detection of Left Atrial Thrombus in Newly Diagnosed Atrial Fibrillation.

Authors:  Ali Sakhnini; Shemy Carasso; Zyad Abu Znait; Shalabi Amjad; Lisa Grossman; Ibrahim Marai
Journal:  J Atr Fibrillation       Date:  2021-08-31

4.  Stroke as the First Manifestation of Atrial Fibrillation.

Authors:  Jussi Jaakkola; Pirjo Mustonen; Tuomas Kiviniemi; Juha E K Hartikainen; Antti Palomäki; Päivi Hartikainen; Ilpo Nuotio; Antti Ylitalo; K E Juhani Airaksinen
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study.

Authors:  Tapio Hellman; Tuomas Kiviniemi; Tuija Vasankari; Ilpo Nuotio; Fausto Biancari; Aissa Bah; Juha Hartikainen; Marianne Mäkäräinen; K E Juhani Airaksinen
Journal:  BMC Cardiovasc Disord       Date:  2017-01-18       Impact factor: 2.298

6.  Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.

Authors:  Samuli Jaakkola; Ilpo Nuotio; Tuomas O Kiviniemi; Raine Virtanen; Melina Issakoff; K E Juhani Airaksinen
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 7.  Use of Direct Oral Anticoagulants Among Patients Undergoing Cardioversion: The Importance of Timing Before Cardioversion.

Authors:  Bruce A Warden; John MacKay; Melika Jafari; Alana Willman; Eric C Stecker
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

8.  Distribution of ischemic strokes in patients with atrial fibrillation: The FibStroke Study.

Authors:  Jussi Jaakkola; Päivi Hartikainen; Tuomas O Kiviniemi; Ilpo Nuotio; Antti Palomäki; Juha E K Hartikainen; Antti Ylitalo; Pirjo Mustonen; K E Juhani Airaksinen
Journal:  Neurol Clin Pract       Date:  2019-08

9.  Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?

Authors:  Stefan Naydenov; Nikolay Runev; Emil Manov
Journal:  Medicina (Kaunas)       Date:  2021-05-31       Impact factor: 2.430

Review 10.  Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies.

Authors:  Wern Yew Ding; Stephanie Harrison; Dhiraj Gupta; Gregory Y H Lip; Deirdre A Lane
Journal:  Front Med (Lausanne)       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.